Latest news
Neuren Pharmaceuticals (ASX:NEU) in Focus on Biotech Progress - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 10:09:00 GMTASX Quarterly Health Wrap: Regulatory wins, clinical progress and strategic growth - StockheadStockhead · Wed, 05 Aug 2026 05:57:53 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Healthcare Earnings Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 01:34:36 GMT